Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up
- PMID: 15747764
- PMCID: PMC1280106
Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up
Abstract
Purpose: To validate a computerized expert system evaluating visual fields in a prospective clinical trial, the Ischemic Optic Neuropathy Decompression Trial (IONDT). To identify the pattern and within-pattern severity of field defects for study eyes at baseline and 6-month follow-up.
Design: Humphrey visual field (HVF) change was used as the outcome measure for a prospective, randomized, multicenter trial to test the null hypothesis that optic nerve sheath decompression was ineffective in treating nonarteritic anterior ischemic optic neuropathy and to ascertain the natural history of the disease.
Methods: An expert panel established criteria for the type and severity of visual field defects. Using these criteria, a rule-based computerized expert system interpreted HVF from baseline and 6-month visits for patients randomized to surgery or careful follow-up and for patients who were not randomized.
Results: A computerized expert system was devised and validated. The system was then used to analyze HVFs. The pattern of defects found at baseline for patients randomized to surgery did not differ from that of patients randomized to careful follow-up. The most common pattern of defect was a superior and inferior arcuate with central scotoma for randomized eyes (19.2%) and a superior and inferior arcuate for nonrandomized eyes (30.6%). Field patterns at 6 months and baseline were not different. For randomized study eyes, the superior altitudinal defects improved (P = .03), as did the inferior altitudinal defects (P = .01). For nonrandomized study eyes, only the inferior altitudinal defects improved (P = .02). No treatment effect was noted.
Conclusions: A novel rule-based expert system successfully interpreted visual field defects at baseline of eyes enrolled in the IONDT.
Figures
Similar articles
-
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial.BMC Ophthalmol. 2006 Nov 20;6:34. doi: 10.1186/1471-2415-6-34. BMC Ophthalmol. 2006. PMID: 17116264 Free PMC article.
-
Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time.Ophthalmology. 2008 Oct;115(10):1809-17. doi: 10.1016/j.ophtha.2008.03.020. Epub 2008 May 16. Ophthalmology. 2008. PMID: 18486224 Free PMC article. Clinical Trial.
-
Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update.Arch Ophthalmol. 2000 Jun;118(6):793-8. Arch Ophthalmol. 2000. PMID: 10865316 Clinical Trial.
-
Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.Eye (Lond). 2004 Nov;18(11):1188-206. doi: 10.1038/sj.eye.6701562. Eye (Lond). 2004. PMID: 15534605 Review.
-
[Ischemic optic neuropathy. Pathogenesis, clinical features, diagnostics and treatment].Klin Oczna. 2006;108(4-6):238-42. Klin Oczna. 2006. PMID: 17020004 Review. Polish.
Cited by
-
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol.Trials. 2022 Oct 29;23(1):916. doi: 10.1186/s13063-022-06786-9. Trials. 2022. PMID: 36309759 Free PMC article.
-
Surgery for nonarteritic anterior ischemic optic neuropathy.Cochrane Database Syst Rev. 2012 Jan 18;1:CD001538. doi: 10.1002/14651858.CD001538.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Mar 12;(3):CD001538. doi: 10.1002/14651858.CD001538.pub4. PMID: 22258945 Free PMC article. Updated.
-
Influence of obstructive sleep apnea syndrome on the contralateral optic nerve in patients with unilateral nonarteritic anterior ischemic optic neuropathy.J Clin Sleep Med. 2023 Feb 1;19(2):347-353. doi: 10.5664/jcsm.10342. J Clin Sleep Med. 2023. PMID: 36305585 Free PMC article.
-
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial.BMC Ophthalmol. 2006 Nov 20;6:34. doi: 10.1186/1471-2415-6-34. BMC Ophthalmol. 2006. PMID: 17116264 Free PMC article.
-
Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time.Ophthalmology. 2008 Oct;115(10):1809-17. doi: 10.1016/j.ophtha.2008.03.020. Epub 2008 May 16. Ophthalmology. 2008. PMID: 18486224 Free PMC article. Clinical Trial.
References
-
- Ischemic Optic Nerve Decompression Trial Group. The Ischemic Optic Neuropathy Decompression Trial (IONDT): design and methods. Control Clin Trials. 1998;19:276–296. - PubMed
-
- Ischemic Optic Nerve Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625–632. - PubMed
-
- Keltner JL, Johnson CA, Beck RW, et al. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT) Control Clin Trials. 1995;14:143–159. - PubMed
-
- Katz J, Congdon N, Friedman D. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol. 1999;117:1137–1142. - PubMed
-
- Molino G, Marzuoli M, Molino F, et al. Validation of ICTERUS, a knowledge-based expert system for jaundice diagnosis. Methods Inf Med. 2000;39:311–318. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical